This month, Managed Care Magazine published an article about a project that tested the feasibility of community pharmacists playing the leading role in PGX testing. The University of North Carolina, Kerr Drug, and LabCorp were involved in the project. Patients who were prescribed clopidogrel underwent pharmacogenetic testing offered by their pharmacist. Based on results, recommendations for medication changes were sent to the prescribing physician and most physician providers accepted those recommendations. Outcomes from this project show that having community pharmacists provide pharmacogenetic testing is a feasible and successful model.
Feel free to read the news release in its entirety here.
Community Pharmacist Pharmacogenetics Network 